In vivo iron labeling of stem cells and tracking these labeled stem cells after their transplantation
View Patent ↗Intravenous ferumoxytol is used to effectively label mesenchymal stem cells (MSCs) in vivo and is used for in vivo tracking of stem cell transplants with magnetic resonance (MR) imaging. The method eliminates risk of contamination and biologic alteration of MSCs associated with ex-vivo-labeling procedures.
1. A method for in vivo and noninvasive monitoring of stem cell implants, comprising:
(a) intravenously injecting iron oxide nanoparticles into a subject to achieve in vivo phagocytotic iron labeling of stem cells;
(b) harvesting from bone marrow of said subject the in vivo iron labeled stem cells;
(c) directly after harvesting, without ex vivo iron labeling of the stem cells, transplanting harvested in vivo iron labeled stem cells into a different subject; and
(d) monitoring in vivo and noninvasively the transplanted in vivo iron labeled stem cells using magnetic resonance imaging.
2. The method as set forth in claim 1 , wherein the stem cells are mesenchymal stem cells.
3. The method as set forth in claim 1 , wherein the harvesting takes place in about one to three days from the intravenous injection.
4. The method as set forth in claim 1 , wherein the intravenous injection of the iron oxide nanoparticles is dosed at 28 mg of iron per kg of body weight of the subject.
5. The method as set forth in claim 1 , wherein the intravenous injection of the iron oxide nanoparticles is dosed at 5-10 mg of iron per kg of body weight of the subject.
6. The method as set forth in claim 1 , wherein the harvested stem cells are transplanted in an organ of a different subject.
7. The method as set forth in claim 1 , wherein the harvested stem cells are transplanted in a joint, a brain, a heart, a liver or a pancreas of a different subject.
8. The method as set forth in claim 1 , wherein the in vivo phagocytotic iron labeling of stem cells occurs in vivo without the use of a transfection agent.
9. The method as set forth in claim 1 , wherein the method does not use any ex vivo labeling or ex vivo manipulations to the stem cells.